Ambrose Kristen — SEC insider filings

SEC reporting owner CIK 1856587. 24 insider filings on record with FilingPulse; latest filed 2026-09-01.

Transaction summary — filings shown

Covers all 24 filings on record, filed 2022-02-03 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
VERTEX PHARMACEUTICALS INC / MA (VRTX)SVP & Chief Accounting Officer24—19 legs · 11,402 sh · $4,926,49226

Insider filings — Ambrose Kristen

FiledFormIssuerReported transactionsSource
2026-09-014VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 5,000 @ $0EDGAR
2026-03-024VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 357 @ $483.36EDGAR
2026-02-264VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 546 @ $485.11 · Sale (S): 223 @ $486.35EDGAR
2026-02-194VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 1,809 @ $0 · Tax withholding (F): 598 @ $483.75 · Sale (S): 1,557 @ $489.46 · Sale (S): 638 @ $473.68EDGAR
2026-02-184VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 1,393 @ $487.76EDGAR
2026-02-124VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 592 @ $468.41 · Sale (S): 1,376 @ $460.43EDGAR
2026-01-264VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 2,950 @ $0 · Grant/award (A): 1,300 @ $0EDGAR
2025-02-284VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 1,241 @ $479.61EDGAR
2025-02-264VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 828 @ $483.28 · Sale (S): 884 @ $480.95EDGAR
2025-02-194VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 564 @ $463.46 · Sale (S): 671 @ $455.06EDGAR
2025-02-144VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 2,080 @ $0EDGAR
2025-02-124VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 591 @ $467.98 · Sale (S): 1,376 @ $459.83EDGAR
2025-02-064VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 2,566 @ $0 · Grant/award (A): 1,854 @ $0EDGAR
2024-04-034VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 225 @ $418.10 · Sale (S): 240 @ $419EDGAR
2024-02-274VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 828 @ $431.79 · Sale (S): 883 @ $425.70EDGAR
2024-02-134VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 591 @ $422.74 · Sale (S): 1,374 @ $420.24EDGAR
2024-02-084VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 2,950 @ $0 · Grant/award (A): 1,853 @ $0EDGAR
2023-06-014VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 289 @ $329.82EDGAR
2023-04-044VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 176 @ $313.74EDGAR
2023-02-284VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 502 @ $289.12 · Sale (S): 982 @ $287.25 · Sale (S): 183 @ $288.68 · Sale (S): 42 @ $289.63EDGAR
2023-02-034VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 2,566 @ $0 · Grant/award (A): 2,950 @ $0EDGAR
2022-04-274VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 60 @ $267.37 · Sale (S): 80 @ $268.46 · Sale (S): 83 @ $269.51 · Sale (S): 104 @ $271.68EDGAR
2022-04-054VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 137 @ $263.09EDGAR
2022-02-034VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 2,566 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2022-01-31 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1856587 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs